Checkpoint Inhibitors-Induced Thyroid Dysfunction

Saturday, May 14, 2022

1:20 PM – 1:40 PM

Location: Breakout Room 3- Sapphire 400 AB (Level 4)

Speaker(s)

Diagnose and manage checkpoint inhibitors-induced thyroid dysfunction
Comprehend the pathogenesis and potential predictors of checkpoint inhibitors-induced thyroid dysfunction
Appreciate the connection between thyroid dysfunction and efficacy of checkpoint inhibitors

Participants should be aware of the following financial/non-financial relationships:

Anupam Kotwal, MD: Horizon Therapeutics, Inc. (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards)